Programme
09H00: Welcome
- 09H30: Institutional partners introduction
- 09H45: Eurobiomed Introduction
- Emilie ROYERE\, Executive Director
- 09H55: "Marseille Immunology Biocluster-MIB" project presentation
- Daniel OLIVE\, M.D.\, PhD\, University professor\, Hospital Practitioner\, Aix-Marseille Université\, Institut Paoli-Calmettes\, Senior member of Institut Universitaire de France
- 10H05: "Innate immunity and inflammation as a metanarrative of medicine\, from cancer to Covid-19"
- Alberto MANTOVANI\, M.D.\, Pr.\, Emeritus Professor of General Pathology and Vice Rector for research at Humanitas University. President of Fondazione Humanitas per la Ricerca
- 10H45: COFFEE BREAK + Posters
Innovative technologies to discover - derisk &\; accelerate
- 11H05: Centre d'Immunologie Marseille-Luminy (CIML)
- Rafael J ARGÜELLO\, PhD\, CNRS Researcher
- 11H25: Deeptope
- Raphael SIEROCKI\, PhD\, Deeptope President
- 11H45: MI-mAbs
- François ROMAGNE\, Pr.\, Professor in immuno-technologies\, Mi-mAbs Scientific Director
- 12H05: Sponsor
- 12H10: LUNCH + Posters
Derisk &\; optimize clinical trials in immune-based therapies
- 13H40: Clinician speaker to be confirmed
- 14H00: Our Future Universe (OFU) speaker to be confirmed
- 14H20: INRIA-COMputational Pharmacology in Oncology (COMPO)
- Joseph CICCOLINI\, Pr.\, Professor of Pharmacokinetics\, Clinical Pharmacologist (PU-PH)
- 14H40: Sponsor
- 14H45: COFFEE BREAK + Posters
New treatment opportunities at clinical stage
- 15H05: ImCheck Therapeutics speaker to be confirmed
- 15H25: Sanofi speaker to be confirmed
- 15H45: Servier
- Jeanne ALLINNE\, PhD\, Head of Immuno-Inflammation Research
- 16H05: Eurobiomed Closing
- Emilie ROYERE\, Executive Director
|
|